All Russian regions have received first trial batches of the "Sputnik V" COVID-19 vaccine, developed for civilian circulation, the Russian Health Ministry’s press service informed reporters on Thursday, APA reports citing Sputnik.
"All regions have received the first trial batches of the Gam-COVID-Vac vaccine (Sputnik V) for the prevention of the novel coronavirus infection developed by the N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology," the message informs.